Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
Settings
SPNC [NASD]
The Spectranetics Corporation
Index- P/E- EPS (ttm)-1.49 Insider Own1.00% Shs Outstand42.39M Perf Week1.20%
Market Cap1.04B Forward P/E- EPS next Y-0.55 Insider Trans-19.34% Shs Float41.74M Perf Month-29.38%
Income-62.50M PEG- EPS next Q-0.29 Inst Own93.80% Short Float15.49% Perf Quarter-27.56%
Sales222.70M P/S4.66 EPS this Y-288.90% Inst Trans0.57% Short Ratio9.43 Perf Half Y-22.24%
Book/sh3.32 P/B7.37 EPS next Y47.60% ROA-13.50% Target Price36.78 Perf Year7.47%
Cash/sh1.03 P/C23.79 EPS next 5Y15.00% ROE-38.00% 52W Range20.96 - 37.04 Perf YTD-29.24%
Dividend- P/FCF- EPS past 5Y-19.00% ROI-9.40% 52W High-33.94% Beta1.03
Dividend %- Quick Ratio2.40 Sales past 5Y12.30% Gross Margin73.90% 52W Low16.75% ATR1.16
Employees753 Current Ratio3.10 Sales Q/Q44.90% Oper. Margin-11.30% RSI (14)29.76 Volatility3.07% 5.38%
OptionableYes Debt/Eq1.65 EPS Q/Q-364.30% Profit Margin-28.10% Rel Volume0.64 Prev Close24.30
ShortableYes LT Debt/Eq1.65 EarningsApr 23 AMC Payout- Avg Volume685.93K Price24.47
Recom1.70 SMA20-5.22% SMA50-21.95% SMA200-21.42% Volume439,100 Change0.70%
Apr-27-15Upgrade Northland Capital Under Perform → Market Perform $25
Apr-24-15Reiterated Stifel Buy $38 → $34
Dec-05-14Reiterated Stifel Buy $35 → $38
Dec-05-14Reiterated Canaccord Genuity Buy $37 → $39
Nov-04-14Reiterated Needham Buy $35 → $38
Jul-21-14Reiterated Canaccord Genuity Buy $27 → $29
Apr-08-14Reiterated Needham Buy $35 → $30
Apr-08-14Reiterated Canaccord Genuity Buy $35 → $30
Mar-21-14Initiated Needham Buy $35
Feb-25-14Reiterated Stifel Buy $24 → $30
Feb-03-14Downgrade Northland Capital Market Perform → Under Perform $20
Nov-26-13Initiated CRT Capital Buy $26.50
Jun-25-13Resumed Stifel Buy $24
May-20-13Downgrade Northland Capital Outperform → Market Perform
Feb-04-13Reiterated Northland Capital Outperform $16 → $20
Sep-07-12Initiated Northland Securities Outperform $16
Apr-25-12Reiterated Barrington Research Outperform $11 → $13
Mar-19-12Reiterated Canaccord Genuity Buy $12 → $14.50
Jul-29-10Reiterated Rodman & Renshaw Mkt Outperform $12 → $9
Jan-08-10Initiated Rodman & Renshaw Mkt Outperform $12
May-15-15 01:04PM  SPECTRANETICS CORP Financials
May-10-15 08:11PM  10-Q for The Spectranetics Corp. at Company Spotlight
May-08-15 03:02PM  SPECTRANETICS CORP Files SEC form 10-Q, Quarterly Report
May-04-15 02:31PM  4 Big-Volume Stocks to Trade for Breakouts at TheStreet +6.91%
Apr-30-15 05:07PM  Spectranetics to Participate in Upcoming Investor Conferences at noodls
04:01PM  Spectranetics to Participate in Upcoming Investor Conferences GlobeNewswire
Apr-29-15 08:53AM  SPECTRANETICS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Apr-27-15 01:51PM  Nasdaq stocks posting largest percentage decreases
06:51AM  Spectranetics upgraded by Northland Capital
Apr-24-15 01:54PM  Spectranetics (SPNC) Stock Slips Today on Weak Earnings Results at TheStreet -23.57%
Apr-23-15 05:42PM  Spectranetics reports 1Q loss
04:29PM  Spectranetics Achieves First Quarter 2015 Revenue of $57.4 Million at noodls
04:29PM  Spectranetics Accelerates Investment in Stellarex(TM) Drug- Coated Balloon Platform for Treatment of Below the Knee (BTK) Peripheral Vascular Disease at noodls
04:06PM  SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Finan
04:03PM  Spectranetics Achieves First Quarter 2015 Revenue of $57.4 Million GlobeNewswire
04:01PM  Spectranetics Accelerates Investment in Stellarex(TM) Drug- Coated Balloon Platform for Treatment of Below the Knee (BTK) Peripheral Vascular Disease GlobeNewswire
07:07AM  Q1 2015 Spectranetics Corp Earnings Release - After Market Close
Apr-16-15 04:44PM  Spectranetics' Stellarex(TM) Drug-coated Balloon Clinical Findings Published in Catheterization and Cardiovascular Interventions at noodls
Apr-13-15 04:11PM  Spectranetics to Hold 2015 First Quarter Financial Results Conference Call on April 23 at noodls
04:01PM  Spectranetics to Hold 2015 First Quarter Financial Results Conference Call on April 23 GlobeNewswire
Mar-19-15 04:32PM  CFO Moves: Aramark, Spectranetics, Smiths Group at The Wall Street Journal
06:01AM  SPECTRANETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Mar-18-15 06:26PM  Spectranetics Announces Chief Financial Officer Transition at noodls
05:45PM  Spectranetics Announces Chief Financial Officer Transition GlobeNewswire
Mar-12-15 04:27PM  Spectranetics Appoints Todd C. Schermerhorn as Director at noodls
04:18PM  SPECTRANETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
04:01PM  Spectranetics Appoints Todd C. Schermerhorn as Director GlobeNewswire
Mar-11-15 05:53AM  Wednesday's Swing Set Ups
Mar-04-15 06:05PM  Elliott Management exits position in Covidien
Mar-01-15 07:09PM  10-K for The Spectranetics Corp. at Company Spotlight
Feb-27-15 05:24PM  SPECTRANETICS CORP Files SEC form 10-K, Annual Report
Feb-19-15 06:28PM  Spectranetics reports 4Q loss
06:21PM  Spectranetics Achieves Fourth Quarter 2014 Revenue of $63.0 Million at noodls
04:30PM  Spectranetics Corp Earnings Call scheduled for 4:30 pm ET today
04:05PM  SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
04:01PM  Spectranetics Achieves Fourth Quarter 2014 Revenue of $63.0 Million GlobeNewswire
07:07AM  Q4 2014 Spectranetics Corp Earnings Release - After Market Close CCBN
Feb-12-15 09:31PM  Endologix, Inc. (ELGX), Quest Diagnostics Inc (DGX), The Spectranetics Corporation (SPNC), and More: Tamarack Capitals Top Picks at Insider Monkey
Feb-05-15 04:01PM  Spectranetics to Hold 2014 Fourth Quarter Financial Results Conference Call on February 19 GlobeNewswire
Feb-04-15 09:07PM  Exclusive: Inside Spectranetics' deal with Medtronic for its drug-coated balloon business at bizjournals.com
Jan-27-15 07:50PM  Medtronic completes blockbuster buy of Covidien; both companies big in Colorado at bizjournals.com
08:22AM  SPECTRANETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
08:20AM  Spectranetics Completes Acquisition of Stellarex(TM) Drug Coated Balloon Assets From Covidien GlobeNewswire
Jan-12-15 06:00AM  SPECTRANETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Dec-31-14 09:46AM  Fourth-quarter miracles: Colorado's 14 biggest 2014 comebacks on Wall Street at American City Business Journals
Dec-29-14 04:02PM  Spectranetics to Present at the J.P. Morgan 33rd Annual Healthcare Conference GlobeNewswire
Dec-17-14 10:36AM  Volcano Up 55% On Acquisition News Benzinga
Dec-05-14 07:31AM  Spectranetics (SPNC) Worth Watching: Stock Rises 7.8% Zacks
Dec-04-14 07:35AM  SPECTRANETICS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online +7.75%
07:30AM  Spectranetics Outlines Growth Opportunities at Analyst & Investor Meeting GlobeNewswire
Nov-26-14 04:26PM  SPECTRANETICS CORP Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
04:01PM  Medtronic gets U.S. antitrust OK to buy Covidien with divestiture Reuters
Nov-25-14 10:35AM  Covidien, Medtronic Shareholders Poised for January Vote TheStreet
09:13AM  Covidien and Medtronic Shareholders Set for a January Vote at TheStreet
Nov-17-14 04:01PM  Spectranetics to Host Investor & Analyst Meeting GlobeNewswire
Nov-14-14 05:55AM  The Spectranetics (SPNC): Strong Industry, Solid Earnings Estimate Revisions Zacks
Nov-08-14 07:07PM  10-Q for The Spectranetics Corp. Company Spotlight
Nov-06-14 04:37PM  SPECTRANETICS CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
10:30AM  Insider Trading Alert - CCL, SYRG And SPNC Traded By Insiders at TheStreet
Nov-05-14 04:01PM  Spectranetics to Participate in Upcoming Investor Conferences GlobeNewswire
Nov-04-14 06:03AM  Can The Spectranetics (SPNC) Keep the Earnings Streak Alive This Quarter? Zacks
Nov-03-14 06:42AM  SPECTRANETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financia EDGAR Online
Nov-02-14 07:00PM  Spectranetics to Acquire Stellarex(TM) Drug Coated Balloon Assets From Covidien GlobeNewswire
Oct-30-14 06:02PM  Nasdaq stocks posting largest percentage increases AP
Oct-27-14 07:13AM  The Spectranetics Corporation (SPNC) in Focus: Stock Soars 13.4% Zacks
Oct-23-14 07:10PM  Spectranetics beats Street 3Q forecasts AP
04:30PM  Spectranetics Corp Earnings Call scheduled for 4:30 pm ET today CCBN
04:05PM  SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
04:01PM  Spectranetics Achieves Third Quarter 2014 Revenue of $58.8 Million GlobeNewswire
07:07AM  Q3 2014 Spectranetics Corp Earnings Release - After Market Close CCBN
Oct-09-14 04:01PM  Spectranetics to Hold 2014 Third Quarter Financial Results Conference Call on October 23 GlobeNewswire
Oct-06-14 04:47PM  SPECTRANETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
Sep-18-14 10:15AM  Insider Trading Alert - HNT, SPNC And MEAS Traded By Insiders at TheStreet
Sep-16-14 11:42AM  EXCITE ISR Proves Superiority in Safety, Efficacy of Laser Atherectomy With PTA vs. PTA Alone; Data Presented at TCT 2014 GlobeNewswire
Sep-10-14 09:29AM  Spectranetics' EXCITE ISR Data to Be Presented at Transcatheter Cardiovascular Therapeutics (TCT) Late-Breaking Clinical Trial Session in Washington, D.C. GlobeNewswire
Aug-20-14 04:01PM  Spectranetics to Participate in Upcoming Investor Conferences GlobeNewswire
Aug-11-14 03:55PM  SPECTRANETICS CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
Jul-30-14 04:53PM  Spectranetics to Present at the Canaccord Genuity 34th Annual Growth Conference GlobeNewswire
Jul-25-14 09:51AM  Spectranetics (SPNC) Highlighted As Today's Perilous Reversal Stock at TheStreet
08:01AM  Spectranetics (SPNC) in Focus: Stock Rises 6.1% Zacks
Jul-24-14 04:30PM  Spectranetics Corp Earnings Call scheduled for 4:30 pm ET today CCBN +6.08%
04:06PM  SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Stateme EDGAR Online
04:01PM  Spectranetics Achieves Second Quarter 2014 Revenue of $43.6 Million GlobeNewswire
03:24PM  Why Spectranetics Corporation Stock Surged Today at Motley Fool
07:57AM  Spectranetics remains a top small cap pick, says Canaccord at theflyonthewall.com
07:07AM  Q2 2014 Spectranetics Earnings Release - After Market Close CCBN
Jul-23-14 04:46PM  Spectranetics receives FDA clearance of peripheral laser atherectomy devices theflyonthewall.com
04:27PM  Spectranetics Announces FDA Clearance of Peripheral Laser Atherectomy Devices for In-Stent Restenosis GlobeNewswire
Jul-21-14 07:50AM  Spectranetics to meet or beat, remains a top small-cap idea, says Canaccord at theflyonthewall.com
Jul-09-14 04:01PM  AngioScore Launches New 200 mm Length AngioSculpt(R) Scoring Balloon Catheters GlobeNewswire
Jul-07-14 04:01PM  Spectranetics to Hold 2014 Second Quarter Financial Results Conference Call on July 24 GlobeNewswire
Jun-30-14 04:05PM  SPECTRANETICS CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, EDGAR Online
04:01PM  Spectranetics Completes Acquisition of AngioScore Inc. GlobeNewswire
Jun-20-14 01:11PM  Volcano acquisition 'really smart,' says Barrington theflyonthewall.com
Jun-18-14 08:43AM  Spectranetics (SPNC): Moving Average Crossover Alert Zacks
Jun-12-14 10:49AM  SPECTRANETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of EDGAR Online
Jun-04-14 12:58PM  EXCITE Clinical Trial Data Reported at NCVH Demonstrates Acute, Superior Procedural Success GlobeNewswire
Jun-03-14 04:38PM  SPECTRANETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obl EDGAR Online
04:01PM  Spectranetics Announces Closing of $230 Million Convertible Senior Notes Offering GlobeNewswire
May-29-14 08:00AM  Spectranetics Announces Pricing of $200 Million Convertible Senior Notes Offering GlobeNewswire
The Spectranetics Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes single-use medical devices used in minimally invasive procedures in the cardiovascular system. Its products are used to cross, prepare, and treat arterial blockages in the legs and heart, and to remove pacemaker and defibrillator cardiac leads. The company's vascular intervention product line includes crossing solutions, which support catheters to facilitate crossing of peripheral and coronary arterial blockages, and retrograde access and guidewire retrieval devices used in the treatment of peripheral arterial blockages, including chronic total occlusions; peripheral atherectomy, a range of laser catheters for ablation of blockages in arteries above and below the knee; and coronary atherectomy and thrombectomy, which are aspiration for the treatment of blockages in the heart. Its primary crossing catheters include Quick-Cross, Quick-Cross Select, and Quick-Cross Extreme; the ELCA Laser Ablation Catheter for coronary atherectomy; and QuickCat aspiration catheter for thrombus management. The company's lead management product line comprises excimer laser sheaths, non-laser mechanical sheaths, and cardiac lead management accessories, such as Spectranetics Laser Sheath, and Lead Locking Device for the removal of pacemaker and defibrillator cardiac leads. It also offers the Stellarex DCB platform that is designed to treat peripheral arterial disease. The company sells its products in the United States, Canada, Europe, the Middle East, the Asia Pacific, Latin America, and Puerto Rico. The Spectranetics Corporation was founded in 1984 and is headquartered in Colorado Springs, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GARDON PAULSr. VP, General CounselMay 13Buy24.353,00073,0503,962May 14 05:44 PM
Drake Scott WilliamPresident, CEOMay 07Option Exercise5.6310,00056,30054,999May 08 05:21 PM
Drake Scott WilliamPresident, CEOMay 07Sale26.1710,000261,69744,999May 08 05:21 PM
CHILDS GUY ACFOMay 05Option Exercise4.9310,00049,300153,729May 06 06:11 PM
PELAK DANIEL ADirectorMay 05Buy25.972,00051,94043,909May 05 05:11 PM
Bowe Wade AVice President R&DMay 01Option Exercise5.7616,16793,12251,124May 01 07:49 PM
PELAK DANIEL ADirectorMay 01Buy23.982,00047,96041,909May 05 05:11 PM
Bowe Wade AVice President R&DMay 01Sale25.4316,167411,20634,957May 01 07:49 PM
Bowe Wade AVice President R&DApr 15Option Exercise0.002,500035,756Apr 17 06:49 PM
Matin ShahriarChief Operating OfficerApr 15Option Exercise0.004,375037,364Apr 17 06:47 PM
CHILDS GUY ACFOApr 15Option Exercise0.006,7000145,871Apr 17 06:45 PM
Bowe Wade AVice President R&DApr 02Option Exercise5.7615,00086,40048,256Apr 03 05:10 PM
Bowe Wade AVice President R&DApr 02Sale34.6715,000519,99333,256Apr 03 05:10 PM
Drake Scott WilliamPresident, CEOMar 05Option Exercise5.6320,000112,60064,999Mar 06 06:43 PM
Drake Scott WilliamPresident, CEOMar 05Sale34.4820,000689,63244,999Mar 06 06:43 PM
Drake Scott WilliamPresident, CEOFeb 05Option Exercise5.6320,000112,60064,999Feb 06 05:07 PM
Drake Scott WilliamPresident, CEOFeb 05Sale33.2020,000664,08244,999Feb 06 05:07 PM
Fuchs Robert MichaelSr. VP, Global Human ResourcesJan 02Option Exercise13.696,00082,1406,990Jan 05 06:42 PM
Drake Scott WilliamPresident, CEOJan 02Option Exercise5.6320,000112,60064,999Jan 05 06:46 PM
Fuchs Robert MichaelSr. VP, Global Human ResourcesJan 02Sale34.486,000206,867990Jan 05 06:42 PM
Drake Scott WilliamPresident, CEOJan 02Sale34.1020,000682,04044,999Jan 05 06:46 PM
Drake Scott WilliamPresident, CEODec 11Option Exercise5.632,65014,92047,649Dec 12 07:01 PM
Drake Scott WilliamPresident, CEODec 11Sale33.901,46849,76546,181Dec 12 07:01 PM
Drake Scott WilliamPresident, CEODec 04Option Exercise5.6380,000450,400124,999Dec 05 07:16 PM
RUGGIO JOSEPH MDirectorNov 03Sale31.805,000158,99552,197Nov 05 09:54 PM
Fuchs Robert MichaelSr. VP, Global Human ResourcesOct 21Option Exercise13.696,00082,1406,990Oct 23 09:32 PM
Fuchs Robert MichaelSr. VP, Global Human ResourcesOct 21Sale28.106,000168,619990Oct 23 09:32 PM
CHILDS GUY ACFOOct 02Option Exercise2.745,00013,700149,857Oct 03 05:54 PM
CHILDS GUY ACFOOct 02Sale26.255,000131,244144,857Oct 03 05:54 PM
RUGGIO JOSEPH MDirectorSep 15Sale28.1910,000281,94857,197Sep 17 07:04 PM
CHILDS GUY ACFOSep 04Option Exercise2.745,00013,700149,857Sep 04 04:21 PM
CHILDS GUY ACFOSep 04Sale28.955,000144,750144,857Sep 04 04:21 PM
Bridges Kimberly McIntoshSr VP, Sales & Mktg, VISep 03Option Exercise15.7910,382163,93210,882Sep 04 04:21 PM
Bridges Kimberly McIntoshSr VP, Sales & Mktg, VISep 03Sale29.3810,382305,054500Sep 04 04:21 PM
Ford-Serbu DonnaSr. VP Sales and Mktg, LMAug 29Option Exercise7.843,00023,5203,513Aug 29 07:21 PM
Ford-Serbu DonnaSr. VP Sales and Mktg, LMAug 29Sale28.263,00084,784513Aug 29 07:21 PM
Drake Scott WilliamPresident, CEOAug 10Option Exercise0.0012,500050,821Aug 12 06:42 PM
CHILDS GUY ACFOAug 07Option Exercise2.745,00013,700149,857Aug 08 06:01 PM
CHILDS GUY ACFOAug 07Sale26.635,000133,125144,857Aug 08 06:01 PM
GARDON PAULSr. VP, General CounselJul 10Option Exercise0.001,41301,413Jul 14 05:40 PM
BYRD AUSTIN BEVANVP, Chief Compliance OfficerJul 10Option Exercise0.006330633Jul 14 05:40 PM
Drake Scott WilliamPresident, CEOJul 10Option Exercise0.009,879043,922Jul 14 05:39 PM
Matin ShahriarChief Operating OfficerJul 10Option Exercise0.002,373033,747Jul 14 05:39 PM
Bowe Wade AVice President R&DJul 10Option Exercise0.00870033,534Jul 14 05:39 PM
Ford-Serbu DonnaSr. VP Sales and Mktg, LMJul 10Option Exercise0.007540754Jul 14 05:38 PM
CHILDS GUY ACFOJul 10Option Exercise0.002,5520146,045Jul 14 05:38 PM
Fuchs Robert MichaelSr. VP, Global Human ResourcesJul 10Option Exercise0.001,16001,360Jul 14 05:38 PM
CHILDS GUY ACFOJun 05Option Exercise2.745,00013,700148,493Jun 05 05:45 PM
CHILDS GUY ACFOJun 05Sale22.005,000110,000143,493Jun 05 05:45 PM
Matin ShahriarChief Operating OfficerJun 01Option Exercise0.002,500032,173Jun 03 03:13 PM
CHILDS GUY ACFOJun 01Option Exercise0.002,9250144,428Jun 03 03:13 PM
Bowe Wade AVice President R&DJun 01Option Exercise0.002,075033,327Jun 03 03:13 PM